Antibiotic Use in Children - A Cross-National Analysis of 6 Countries

Ilan Youngster1, Jerry Avorn2, Valeria Belleudi3

  • 1Division of Infectious Diseases, Boston Children's Hospital, Boston, MA.

The Journal of Pediatrics
|December 26, 2016
PubMed

Insights

Pediatric antibiotic use varied significantly across six countries, with South Korea showing the highest rates. These findings highlight the need for strategies to reduce unnecessary antimicrobial prescriptions in children.

Area of Science:

  • Global Health
  • Pediatrics
  • Pharmacology

Background:

  • Antibiotic resistance is a growing global concern.
  • Appropriate antibiotic use in children is crucial for effective treatment and minimizing resistance.
  • Understanding international variations in pediatric antibiotic prescribing is essential for public health initiatives.

Purpose of the Study:

  • To quantify and compare rates of pediatric antibiotic use across diverse countries.
  • To identify significant differences in antimicrobial consumption among children globally.

Main Methods:

  • A cross-national analysis of 7 pediatric cohorts from 2008-2012.
  • Inclusion of data from 6 countries: Germany, Italy, South Korea, Norway, Spain, and the US.
  • Calculation of antimicrobial prescription rates per person-year by age group.

Main Results:

  • Substantial international variations in pediatric antimicrobial use were observed, with differences up to 7.5-fold.
  • South Korea exhibited the highest infant antimicrobial consumption (3.41 courses/child-year), while Norway had the lowest (0.5 courses/child-year).
  • Prescription patterns varied, with Norway predominantly using first-line penicillins (64.8%) compared to South Korea (9.8%).

Conclusions:

  • Significant disparities in pediatric antibiotic prescribing exist among industrialized nations.
  • The findings underscore the necessity for developing targeted strategies to curb unnecessary antimicrobial use in children.
  • International collaboration is vital for promoting rational antibiotic stewardship in pediatric populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Antibiotic Selection00:57

Antibiotic Selection

Overview
61.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
595
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.7K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
637
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306